Fig. 11

Establishment and validation of the nomogram based on clinicopathological characteristics and risk score. a Nomogram for risk score and clinical characteristics in patients with HCC. b Calibration analysis of the risk score containing nomogram for 1-, 2-, 3- year OS. c 1-year, (d) 2-year and (e) 3-year ROC analysis for the nomogram. *p < 0.05, **p < 0.01, and ***p < 0.001. HCC, hepatocellular carcinoma; OS, overall survival; ROC, receiver operating characteristic curve